The Journal of
Clinical Psychiatry

Suicide

Academic Highlights September 15, 2003

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders.

J Clin Psychiatry 2003;64(9):1122-1129

Article Abstract

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders. [CME]

Download Free PDF

Enjoy free PDF downloads as part of your membership!

Save Save

Cite

Advertisement
GAM ID: sidebar-top

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Advertisement
GAM ID: sidebar-bottom

Related Articles

Shared or Induced Olfactory Reference Syndrome

Academic Highlights

Shared or Induced Olfactory Reference Syndrome

December 7, 2023

Olfactory reference syndrome (ORS) is an underrecognized condition characterized by preoccupation with body odor accompanied by significant distress and functional impairment This is a case of 2 sisters with...

N. A. Uvais, Shamsudeen Moideen

Optimizing Women's Health: Mood Disorders Through Lifespan

Academic Highlights

Optimizing Women's Health: Mood Disorders Through Lifespan

September 18, 2023

Mood disorders throughout women's reproductive stages require comprehensive care to alleviate unnecessary suffering, comorbidities, and unwanted outcomes.

Kathryn M. Abel, Marlene P. Freeman

Racial and Ethnic Disparities in Health Care and Clinical Trials

Academic Highlights

Racial and Ethnic Disparities in Health Care and Clinical Trials

June 12, 2023

This Academic Highlights traces the history of scientific racism from the colonization of the US to the present, illustrating the problem of low diversity in clinical trials and outlining...

Inez Ruiz-White, Luke Kramer, Lionel Philips, et al